Table 3. Estimates of Female Effective Population Size (NEF) and population growth.
Population | Theta | CI 95% | Mean NEF | CI 95% | Growth 1 | CI 95% |
---|---|---|---|---|---|---|
ART1 | 5.77x10–3 | 2.43x10–3–1.58x10–2 | 50,157 | 21,104–136,974 | NS | NS |
ART2 | 1.62x10–3 | 4.56x10–4–5.34x10–3 | 14,043 | 3,965–46,426 | NS | NS |
BR290 | 8.81x10–4 | 1.41x10–4–3.14x10–3 | 7,661 | 1,226–27,270 | NS | NS |
BR293 | 4.51x10–3 | 1.90x10–3–1.09x10–2 | 39,174 | 16,513–94,870 | NS | NS |
CJA | 1.90x10–3 | 6.13x10–4–5.65x10–3 | 16,530 | 5,330–49,157 | NS | NS |
CTI | 2.06x10–3 | 6.46x10–4–6.30x10–3 | 17,922 | 5,617–54,739 | NS | NS |
CVE 2 | 5.16x10–2 | 8.84x10–3–2.94x100 | 448,965 | 76,852–23,454,843 | 1613 | 408–6063 |
CVE 3 | 7.71x10–3 | 3.34x10–3–1.98x10–2 | 67,070 | 29,070–172,026 | 0* | 0* |
PAY | 1.78x10–3 | 4.62x10–4–5.32x10–3 | 15,461 | 4,017–46,217 | NS | NS |
RIV | 4.08x10–3 | 1.40x10–3–1.45x10–2 | 35,443 | 12,191–126,113 | NS | NS |
FCB | 1.01x10–3 | 2.25x10–4–3.53x10–3 | 8,748 | 1,957–30,704 | NS | NS |
SAL | 1.57x10–5 | 1.01x10–5–6.98x10–4 | 137 | 88–6,070 | NS | NS |
Clade I | 2.06x10–3 | 6.46x10–4–6.30x10–3 | 17,922 | 5,617–54,739 | NS | NS |
Clade II | 9.05x10–3 | 5.44x10–3–1.61x10–2 | 78,730 | 47,339–140,191 | NS | NS |
Clade III | 3.12x10–3 | 1.22x10–3–8.45x10–3 | 27,165 | 10,574–73,496 | NS | NS |
Clade IV | 2.05x10–2 | 1.38x10–2–3.02x10–2 | 178,026 | 119,626–262,296 | 283 | 33–315 |
“Peripheral” Populations 4 | 1.95x10–2 | 1.37x10–2–2.96x10–2 | 169,487 | 119,148–257,148 | NS | NS |
All Populations | 3.89x10–2 | 3.09x10–2–5.17x10–2 | 337,904 | 268,452–449,235 | NS | NS |
CI 95%- 95% Credible interval for the estimates.
1Prior bounds for population growth between-5,000 and 15,000.
2Estimates for female effective population size assuming exponential population growth.
3Estimates for female effective population size assuming constant population size.
4”Peripheral” populations include Clades I, II and III. NS—Not significant.
*See text for details.